ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi ...
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro and Zepbound.
Pharmaceutical Technology15d
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
Data from the Phase III PURPOSE 1 and PURPOSE 2 trials demonstrated lenacapavir’s superior HIV prevention efficacy compared to Gilead’s once-daily oral Truvada (emtricitabine + tenofovir disoproxil ...
publichealth.jhu24d
What to Know About PrEP
Truvada contains emtricitabine and tenofovir disoproxil fumarate. The latter is an older form of tenofovir that has been associated with possible kidney and bone side effects, though it is generally ...
Healthline25d
Descovy vs. Truvada: What You Should Know
Strengths of Truvada are listed in mg of emtricitabine/tenofovir disoproxil fumarate. Below are the dosages of Descovy and Truvada for treating or helping prevent HIV in children. Strengths of ...
Frontiers27d
Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
Compared with the entecavir group, patients in the tenofovir group, including tenofovir disoproxil fumarate and tenofovir alafenamide fumarate showed a significant increase in estimated glomerular ...
The American Journal of Managed Care29d
5 Medications That Defer Blood Donation
Taken as a preventive measure against acquiring HIV, and meant to lower acquisition risk, Truvada (emtricitabine/tenofovir disoproxil fumarate; Gilead), Descovy (emtricitabine/tenofovir ...